Copa Syndrome: a Novel Autosomal Dominant Immune Dysregulatory Disease

Journal of Clinical Immunology

Volumn 36, Issue 4, 2016, Pages 377-387

  Vece, Timothy J ^a   Watkin, Levi B ^a,b   Nicholas, Sarah K ^a,b   Canter, Debra ^b   Braun, Michael C ^a   Guillerman, Robert Paul ^b   Eldin, Karen W ^a   Bertolet, Grant ^a,b   McKinley, Scott D ^a   de Guzman, Marietta ^a,b   Forbes, Lisa R ^a,b   Chinn, Ivan ^a,b   Orange, Jordan S ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

arthritis; Autoimmunity; autosomal dominant; interstitial lung disease; primary immunodeficiency

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; COATOMER PROTEIN; COP ALPHA PROTEIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; ETANERCEPT; HYDROXYCHLOROQUINE; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 6; METHOTREXATE; NEUTROPHIL CYTOPLASMIC ANTIBODY; RAPAMYCIN; RITUXIMAB; UNCLASSIFIED DRUG;

ARTHRITIS; AUTOPHAGY; AUTOSOMAL DOMINANT DISORDER; BONE NECROSIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; COPA SYNDROME; COUGHING; CYTOKINE RELEASE; END STAGE RENAL DISEASE; ENDOPLASMIC RETICULUM STRESS; GENE MUTATION; GENETIC LINKAGE; GENETIC VARIABILITY; GLOMERULONEPHRITIS; GLOMERULOPATHY; GOLGI COMPLEX; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNE DEFICIENCY; IMMUNE DYSREGULATION; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; LUNG HEMORRHAGE; MOLECULAR PATHOLOGY; NONHUMAN; PATHOGENESIS; POPULATION; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; TACHYPNEA; TH17 CELL; GENETICS; IMMUNOLOGY; KIDNEY DISEASE; LUNG DISEASE; PATHOLOGY;

ARTHRITIS; COATOMER PROTEIN; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; KIDNEY DISEASES; LUNG DISEASES;

EID: 84962714625     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-016-0271-8     Document Type: Review

References (49)

1. Picard C, Al-Herz W, Bousfiha A, Casanova J-L, Chatila T, Conley ME, et al. Primary Immunodeficiency Diseases: an Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015. J Clin Immunol. Springer US; 2015; 1–31.
2. Melki I, Crow YJ. Novel monogenic diseases causing human autoimmunity. Curr Opin Immunol. 2015;37:1–5.
3. Brown KK. Pulmonary vasculitis. Proc Am Thorac Soc. 2006;3:48–57.
4. Sacri A-S, Chambaraud T, Ranchin B, Florkin B, Sée H, Decramer S, et al. Clinical characteristics and outcomes of childhood-onset ANCA-associated vasculitis: a French nationwide study. Nephrol Dial Transplant. 2015;30 Suppl 1:i104–12.
5. Siomou E, Tramma D, Bowen C, Milford DV. ANCA-associated glomerulonephritis/systemic vasculitis in childhood: clinical features-outcome. Pediatr Nephrol. 2012;27:1911–20. Springer-Verlag.
6. Morishita K, Li SC, Muscal E, Spalding S, Guzman J, Uribe A, et al. Assessing the performance of the Birmingham Vasculitis Activity Score at diagnosis for children with antineutrophil cytoplasmic antibody-associated vasculitis in A Registry for Childhood Vasculitis (ARChiVe). J Rheumatol. 2012;39:1088–94.
7. Barile-Fabris L, Hernández-Cabrera MF, Barragan-Garfias JA. Vasculitis in systemic lupus erythematosus. Curr Rheumatol Rep. 2014;16:440–6. Springer US.
8. Kobayashi N, Takezaki S, Kobayashi I, Iwata N, Mori M, Nagai K, et al. Clinical and laboratory features of fatal rapidly progressive interstitial lung disease associated with juvenile dermatomyositis. Rheumatology (Oxford). 2015;54:784–91. Oxford University Press.
9. Burns NS, Stevens AM, Iyer RS. Shrinking lung syndrome complicating pediatric systemic lupus erythematosus. Pediatr Radiol. 2014;44:1318–22. Springer Berlin Heidelberg.
10. Valeur NS, Stevens AM, Ferguson MR, Effmann EL, Iyer RS. Multimodality thoracic imaging of juvenile systemic sclerosis: emphasis on clinical correlation and high-resolution CT of pulmonary fibrosis. AJR Am J Roentgenol. 2015;204:408–22.
11. Liu Y, Jesus AA, Marrero B, Yang D, Ramsey SE, Montealegre Sanchez GA, et al. Activated STING in a vascular and pulmonary syndrome. N Engl J Med. 2014;371:507–18.
12. Jeremiah N, Neven B, Gentili M, Callebaut I, Maschalidi S, Stolzenberg M-C, et al. Inherited STING-activating mutation underlies a familial inflammatory syndrome with lupus-like manifestations. J Clin Invest. 2014;124:5516–20. American Society for Clinical Investigation.
13. Amberger JS, Bocchini CA, Schiettecatte F, Scott AF, Hamosh A. OMIM.org: Online Mendelian Inheritance in Man (OMIM®), an online catalog of human genes and genetic disorders. Nucleic Acids Res. 2015;43:D789–98.
14. Watkin LB, Jessen B, Wiszniewski W, Vece TJ, Jan M, Sha Y, et al. COPA mutations impair ER-Golgi transport and cause hereditary autoimmune-mediated lung disease and arthritis. Nat Genet. 2015;47:654–60.
15. Kuehn HS, Ouyang W, Lo B, Deenick EK, Niemela JE, Avery DT, et al. Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4. Science. 2014;345:1623–7. American Association for the Advancement of Science.
16. Schubert D, Bode C, Kenefeck R, Hou TZ, Wing JB, Kennedy A, et al. Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations. Nat Med. 2014;20:1410–6. Nature Publishing Group.
17. Milner JD, Vogel TP, Forbes L, Ma CA, Stray-Pedersen A, Niemela JE, et al. Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations. Blood. 2015;125:591–9. American Society of Hematology.
18. Lo B, Zhang K, Lu W, Zheng L, Zhang Q, Kanellopoulou C, et al. AUTOIMMUNE DISEASE. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy. Science. 2015;349:436–40. American Association for the Advancement of Science.
19. Tashtoush B, Okafor NC, Ramirez JF, Smolley L. Follicular bronchiolitis: a literature review. J Clin Diagn Res. 2015;9:OE01–5.
20. Gomes VCC, Silva MCC, Maia Filho JH, Daltro P, Ramos SG, Brody AS, et al. Diagnostic criteria and follow-up in neuroendocrine cell hyperplasia of infancy: a case series. J Bras Pneumol. 2013;39:569–78.
21. Hamamoto Y, Ito H, Furu M, Hashimoto M, Fujii T, Ishikawa M, et al. Serological and Progression Differences of Joint Destruction in the Wrist and the Feet in Rheumatoid Arthritis - A Cross-Sectional Cohort Study. PLoS ONE. 2015;10:e0136611. Fang D, editor Public Library of Science.
22. Schekman R, Orci L. Coat proteins and vesicle budding. Science. 1996;271:1526–33.
23. Barlowe C, Orci L, Yeung T, Hosobuchi M, Hamamoto S, Salama N, et al. COPII: a membrane coat formed by Sec proteins that drive vesicle budding from the endoplasmic reticulum. Cell. 1994;77:895–907.
24. Waters MG, Serafini T, Rothman JE. “Coatomer”: a cytosolic protein complex containing subunits of non-clathrin-coated Golgi transport vesicles. Nature. 1991;349:248–51.
25. Jackson LPL, Lewis MM, Kent HMH, Edeling MAM, Evans PRP, Duden RR, et al. Molecular basis for recognition of dilysine trafficking motifs by COPI. Dev Cell. 2012;23:1255–62.
26. Letourneur F, Gaynor EC, Hennecke S, Démollière C, Duden R, Emr SD, et al. Coatomer is essential for retrieval of dilysine-tagged proteins to the endoplasmic reticulum. Cell. 1994;79:1199–207.
27. Chakrabarti A, Chen AW, Varner JD. A review of the mammalian unfolded protein response. Biotechnol Bioeng. 2011;108:2777–93. Wiley Subscription Services, Inc., A Wiley Company.
28. Diehl JA, Fuchs SY, Koumenis C. The cell biology of the unfolded protein response. Gastroenterology. 2011;141:38–41.e2.
29. Deniaud A, el dein Sharaf O, Maillier E, Poncet D, Kroemer G, Lemaire C, et al. Endoplasmic reticulum stress induces calcium-dependent permeability transition, mitochondrial outer membrane permeabilization and apoptosis. Oncogene. 2008;27:285–99.
30. Pahl HL, Baeuerle PA. Activation of NF-kappa B by ER stress requires both Ca2+ and reactive oxygen intermediates as messengers. FEBS Lett. 1996;392:129–36.
31. Muralidharan S, Mandrekar P. Cellular stress response and innate immune signaling: integrating pathways in host defense and inflammation. J Leukoc Biol. 2013;94:1167–84. Society for Leukocyte Biology.
32. Deng J, Lu PD, Zhang Y, Scheuner D, Kaufman RJ, Sonenberg N, et al. Translational repression mediates activation of nuclear factor kappa B by phosphorylated translation initiation factor 2. Mol Cell Biol. 2004;24:10161–8. American Society for Microbiology.
33. Nakajima S, Hiramatsu N, Hayakawa K, Saito Y, Kato H, Huang T, et al. Selective abrogation of BiP/GRP78 blunts activation of NF-κB through the ATF6 branch of the UPR: involvement of C/EBPβ and mTOR-dependent dephosphorylation of Akt. Mol Cell Biol. 2011;31:1710–8. American Society for Microbiology.
34. Sidrauski C, Walter P. The transmembrane kinase Ire1p is a site-specific endonuclease that initiates mRNA splicing in the unfolded protein response. Cell. 1997;90:1031–9.
35. Iwakoshi NN, Lee A-H, Vallabhajosyula P, Otipoby KL, Rajewsky K, Glimcher LH. Plasma cell differentiation and the unfolded protein response intersect at the transcription factor XBP-1. Nat Immunol. 2003;4:321–9. Nature Publishing Group.
36. Urano F, Wang X, Bertolotti A, Zhang Y, Chung P, Harding HP, et al. Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science. 2000;287:664–6.
37. Hu P, Han Z, Couvillon AD, Kaufman RJ, Exton JH. Autocrine tumor necrosis factor alpha links endoplasmic reticulum stress to the membrane death receptor pathway through IRE1alpha-mediated NF-kappaB activation and down-regulation of TRAF2 expression. Mol Cell Biol. 2006;26:3071–84. American Society for Microbiology.
38. Kaneko M, Niinuma Y, Nomura Y. Activation signal of nuclear factor-kappa B in response to endoplasmic reticulum stress is transduced via IRE1 and tumor necrosis factor receptor-associated factor 2. Biol Pharm Bull. 2003;26:931–5.
39. Yorimitsu T, Nair U, Yang Z, Klionsky DJ. Endoplasmic reticulum stress triggers autophagy. J Biol Chem. 2006;281:30299–304. American Society for Biochemistry and Molecular Biology.
40. Claerhout SS, Dutta BB, Bossuyt WW, Zhang FF, Nguyen-Charles CC, Dennison JBJ, et al. Abortive autophagy induces endoplasmic reticulum stress and cell death in cancer cells. PLoS ONE. 2012;7, e39400. Langsley G, editor.
41. Liang Q, Seo GJ, Choi YJ, Kwak M-J, Ge J, Rodgers MA, et al. Crosstalk between the cGAS DNA sensor and Beclin-1 autophagy protein shapes innate antimicrobial immune responses. Cell Host Microbes. 2014;15:228–38.
42. Konno H, Konno K, Barber GN. Cyclic dinucleotides trigger ULK1 (ATG1) phosphorylation of STING to prevent sustained innate immune signaling. Cell. 2013;155:688–98.
43. Dupont N, Jiang S, Pilli M, Ornatowski W, Bhattacharya D, Deretic V. Autophagy‐based unconventional secretory pathway for extracellular delivery of IL‐1β. EMBO J. 2011;30:4701–11. EMBO Press.
44. Harris J, Hartman M, Roche C, Zeng SG, O’Shea A, Sharp FA, et al. Autophagy controls IL-1beta secretion by targeting pro-IL-1beta for degradation. J Biol Chem. 2011;286:9587–97. American Society for Biochemistry and Molecular Biology.
45. Nakahira K, Haspel JA, Rathinam VAK, Lee S-J, Dolinay T, Lam HC, et al. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol. 2011;12:222–30.
46. Zhou R, Yazdi AS, Menu P, Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature. 2011;469:221–5.
47. de Castro Peral C, de Castro CP, Jones SA, Ní Cheallaigh C, Cheallaigh CN, Hearnden CA, et al. Autophagy regulates IL-23 secretion and innate T cell responses through effects on IL-1 secretion. J Immunol. 2012;189:4144–53. American Association of Immunologists.
48. Schuster C, Gerold KD, Schober K, Probst L, Boerner K, Kim M-J, et al. The autoimmunity-associated gene CLEC16A modulates thymic epithelial cell autophagy and alters T cell selection. Immunity. 2015;42:942–52.
49. Nedjic J, Aichinger M, Emmerich J, Mizushima N, Klein L. Autophagy in thymic epithelium shapes the T-cell repertoire and is essential for tolerance. Nature. 2008;455:396–400.